Colchicine prophylaxis in pseudogout.

Area of Science:

• Rheumatology
• Pharmacology

Background:

• Pseudogout, characterized by recurrent acute arthritis, significantly impacts patient quality of life.
• Effective prophylactic treatments for pseudogout are crucial for managing chronic conditions.

Purpose of the Study:

• To evaluate the efficacy of oral colchicine as a prophylactic agent for recurrent pseudogout attacks.

Main Methods:

• A prospective study followed ten patients with recurrent pseudogout for one year.
• Patients received oral colchicine 0.6 mg twice daily, with arthritis episodes recorded pre- and post-treatment.

Main Results:

• A significant reduction in acute arthritis episodes was observed, from 3.2 per patient per year to 1 per patient per year (p < 0.001).
• Ninety percent of patients experienced clinical benefit from oral colchicine prophylaxis.

Conclusions:

• Oral colchicine is an effective prophylactic treatment for reducing the frequency of pseudogout attacks.
• The findings support the use of colchicine in managing patients with recurrent pseudogout.